Cargando…
Analysis of HER2 genomic binding in breast cancer cells identifies a global role in direct gene regulation
HER2 is a transmembrane receptor tyrosine kinase, which plays a key role in breast cancer due to a common genomic amplification. It is used as a marker to stratify patients in the clinic and is targeted by a number of drugs including Trastuzumab and Lapatinib. HER2 has previously been shown to trans...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6867699/ https://www.ncbi.nlm.nih.gov/pubmed/31747426 http://dx.doi.org/10.1371/journal.pone.0225180 |